We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Home BancShares
HOMB
$5.95B
| $604K | ﹤0.01% |
26,502
+5,758
| +28% | +$126K |
|
1302
Byrna Technologies
BYRN
$86.8M
| $601K | ﹤0.01% |
120,000
+70,000
| +140% | +$378K |
|
|
ASAI
1303
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| – | – |
0
| – | – |
|
1304
Doximity
DOCS
$4.62B
| $601K | ﹤0.01% |
17,658
-30,092
| -63% | -$1M |
|
1305
FNB Corp
FNB
$6.37B
| $595K | ﹤0.01% |
52,015
+1,080
| +2% | +$12.2K |
|
|
NXRT
1306
NexPoint Residential Trust
NXRT
$545M
| $592K | ﹤0.01% |
13,026
+3,171
| +32% | +$137K |
|
|
NVEI
1307
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $591K | ﹤0.01% |
20,000
+10,000
| +100% | +$352K |
|
1308
Tyson Foods
TSN
$18.3B
| $588K | ﹤0.01% |
11,528
+11,513
| +76,753% | +$627K |
|
1309
Hawaiian Electric Industries
HE
$1.77B
| $588K | ﹤0.01% |
16,235
+209
| +1% | +$7.87K |
|
1310
Atmos Energy
ATO
$27.4B
| $584K | ﹤0.01% |
5,023
+4,115
| +453% | +$476K |
|
1311
Ally Financial
ALLY
$12.3B
| $582K | ﹤0.01% |
21,546
+4,307
| +25% | +$115K |
|
|
OPLN
1312
Openlane
OPLN
$4.28B
| $581K | ﹤0.01% |
38,176
-7,227
| -16% | -$105K |
|
|
TGNA
1313
DELISTED
TEGNA Inc
TGNA
| $577K | ﹤0.01% |
35,533
-1,686
| -5% | -$27.5K |
|
1314
Norfolk Southern
NSC
$71.2B
| $575K | ﹤0.01% |
2,534
-744
| -23% | -$158K |
|
|
SGMO
1315
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $573K | ﹤0.01% |
440,935
+120,899
| +38% | +$165K |
|
1316
BCB Bancorp
BCBP
$149M
| $571K | ﹤0.01% |
48,613
-100
| -0.2% | -$1.14K |
|
1317
GoDaddy
GDDY
$12.5B
| $570K | ﹤0.01% |
7,593
-3,712
| -33% | -$274K |
|
1318
Integra LifeSciences
IART
$1.25B
| $569K | ﹤0.01% |
13,845
+562
| +4% | +$27K |
|
1319
MDU Resources
MDU
$3.92B
| $567K | ﹤0.01% |
48,883
-25,900
| -35% | -$291K |
|
|
LL
1320
DELISTED
LL Flooring Holdings, Inc.
LL
| $567K | ﹤0.01% |
147,950
+145,881
| +7,051% | +$564K |
|
1321
Valaris
VAL
$5.73B
| $566K | ﹤0.01% |
8,995
-201
| -2% | -$12.1K |
|
|
JHG
1322
DELISTED
Janus Henderson
JHG
| $561K | ﹤0.01% |
20,582
+223
| +1% | +$5.95K |
|
1323
Vinci Compass Investments Ltd
VINP
$607M
| $559K | ﹤0.01% |
60,000
-55,000
| -48% | -$467K |
|
1324
Sabesp
SBS
$18.6B
| $558K | ﹤0.01% |
242,872
| – | – |
|
1325
Cabot Corp
CBT
$4.05B
| $556K | ﹤0.01% |
8,313
+289
| +4% | +$20.6K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.